EGFR and colorectal carcinoma: The 5-fluorouracil (5-FU)-based chemotherapy, anti-VEGF (vascular endothelial growth factor) (bevacizumab), and anti-EGFR (epidermal growth factor receptor) (cetuximab) therapies are the first-line treatment options for CRC (Andrei et al., 2022).